CapExchange: A Pilot Feasibility Study of a Capacity-Exchange Programme for Mental Health Recovery (CapExchange)

June 24, 2026 updated by: EPSM de la Guadeloupe

CapExchange: Study Protocol for a Pilot Feasibility Study of a Capacity-Exchange Programme for Mental Health Recovery

CapExchange is a psychosocial rehabilitation programme based on reciprocal exchange of capacities and services between service users and their community environment, grounded in the concepts of circular mutuality and micro-social contribution. This pilot feasibility study aims to assess the feasibility and acceptability of the programme within the Psychosocial Rehabilitation Service of the EPSM de la Guadeloupe, across three sites: the Unité Passerelle, the CATTG Doubs, and the UREPS outpatient unit. A sample of 10 to 15 adult service users with a stabilized mental disorder is targeted. The intervention comprises five weekly group sessions of 75 minutes. Primary measures include the Social Contribution Score (SCS) and the Warwick-Edinburgh Mental Well-being Scale (WEMWBS).

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

15

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Adults aged 18 years or over
  • Stabilized mental disorder (no acute episode in the 3 months preceding inclusion)
  • At least one identifiable practical skill exchangeable in a community context
  • Free and informed consent to participation

Exclusion Criteria:

  • Severe clinical instability at the time of inclusion
  • Uncontrolled risk behaviour in social interactions
  • Documented inability to engage in a reciprocity-based framework
  • Opposition from legal guardian for service users under legal protection'

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: CapExchange Programme
Five weekly group sessions of 75 minutes based on reciprocal exchange of capacities and services between service users and their community environment.
Behavioral: CapExchange
A structured group programme comprising five weekly sessions of 75 minutes based on reciprocal exchange of capacities and services between service users and their community environment, grounded in the concepts of circular mutuality and micro-social contribution.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Recruitment rate
Time Frame: 3 months
Proportion of eligible service users agreeing to participate in the programme
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

EPSM de la Guadeloupe

Investigators

  • Principal Investigator: Ilyass El Mahfoudi, MD, EPSM Guadeloupe

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

January 4, 2027

Primary Completion (Estimated)

September 15, 2027

Study Completion (Estimated)

December 20, 2027

Study Registration Dates

First Submitted

May 27, 2026

First Submitted That Met QC Criteria

May 27, 2026

First Posted (Actual)

June 2, 2026

Study Record Updates

Last Update Posted (Actual)

June 29, 2026

Last Update Submitted That Met QC Criteria

June 24, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CapExchange-2026-001

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data will not be shared given the pilot and feasibility nature of this study and the small sample size.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe